-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Overweight on WAVE Life Sciences, Raises Price Target to $34

Benzinga·12/09/2025 13:50:41
Listen to the news
Cantor Fitzgerald analyst Steve Seedhouse maintains WAVE Life Sciences (NASDAQ:WVE) with a Overweight and raises the price target from $12 to $34.